Paper Details

  1. Home
  2. Paper Details

The efficacy and safety of Vibegron in treating overactive bladder: A systematic review and pooled analysis of randomized controlled trials.

Author: ChenHongyan, CuiYuanshan, ShiHongbin, ZhangYong

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Vibegron, a β3-adrenergic receptor agonist, significantly improved overactive bladder symptoms in patients compared to placebo. The treatment was well-tolerated with a favorable safety profile, with dry mouth being the most common side effect.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: Vibegron is a new kind of β3-adrenergic receptor agonist. We performed a systematic review and pooled analysis to assess the efficacy, safety, and tolerability of Vibegron for treating overactive bladder (OAB). METHODS: MEDLINE, the Cochrane Controlled Trial Register and EMBASE were used...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/nau.24387

データ提供：米国国立医学図書館（NLM）

Vibegron: A New Hope for Overactive Bladder

Overactive bladder is a common and often embarrassing condition that can significantly impact quality of life. This research explores a new medication, [Vibegron], for treating this condition, seeking to alleviate symptoms and improve bladder control. It's like finding a new source of water in the desert, offering a refreshing solution to a persistent problem.

The study examined the efficacy and safety of [Vibegron] for treating [overactive bladder (OAB)]. The researchers analyzed the [changes in bladder symptoms] after treatment with [Vibegron]. The findings suggest that [Vibegron] is an effective treatment option for OAB, offering a potential solution for improving bladder control and reducing symptoms. It's like discovering a new path through the desert, one that leads to a smoother journey and a more comfortable experience.

Vibegron: A Potential Solution for Overactive Bladder

The study found that [specific findings regarding the effectiveness of Vibegron for treating OAB]. This suggests that [implication of the findings] . It's like finding a new source of water in the desert, offering a way to quench the thirst and improve the well-being of those suffering from OAB.

A More Comfortable Journey: Managing Overactive Bladder

This research highlights the potential of [Vibegron] to improve the quality of life for those living with overactive bladder. It offers a new approach to managing this condition, potentially reducing symptoms and improving bladder control. It's like finding a new way to navigate the desert, one that is smoother, less bumpy, and more comfortable.

Dr.Camel's Conclusion

This research provides a valuable contribution to the management of overactive bladder. It offers a new treatment option, [Vibegron], with the potential to improve bladder control and quality of life for patients. It's like finding a new oasis in the desert, a place where people can find relief and rejuvenation from the challenges of overactive bladder.

Date :
  1. Date Completed 2020-12-07
  2. Date Revised 2020-12-14
Further Info :

Pubmed ID

32421908

DOI: Digital Object Identifier

10.1002/nau.24387

Related Literature

Article Analysis
・Effects of vibegron
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.